Speakers

Plenary Lecturers

“How far are we from a complete and reliable compositional assessment of natural extracts: Perspectives for the development of new ingredients and drug discovery”

Jean‐Luc Wolfender

University of Geneva – Switzerland

Jean‐Luc Wolfender is a Professor at the University of Geneva and leads the Phytochemistry Bioactive Natural Product (PBNP) group.

His research focuses on LC-MS and LC-NMR profiling of natural extracts, metabolomics, and natural product-based drug discovery…

[Read More]

“The New Era of Pharmaceutical Analysis: An Industry Perspective”

Kelly Zhang

Genentech, Roche Group – USA

Kelly Zhang, Ph.D., is a Senior Fellow and Director at Genentech (a member of the Roche Group). She has over 20 years of diverse pharmaceutical industry experience from Genentech, Allergan, and Pfizer. She has led analytical R&D teams from preclinical research to commercial launches, across both drug substances and drug formulations…

[Read More]

“Pathogenic mAbs, large metastable immune complexes and activated platelets: mass
spectrometry reveals the mechanism of a deadly vaccine side effect”

Igor A. Kaltashov

University of Massachusetts – Amherst – USA

Igor A. Kaltashov holds a Ph.D. in Chemistry and is a Professor in the Chemistry Department at the University of Massachusetts-Amherst.

His research focuses on mass spectrometry-based techniques for studying biopolymers, with collaborations involving Amgen, Biogen, and Pfizer…

[Read More]

“The challenges of the analysis of novel pharmaceutical entities and the nitrosamines”

Adrian Clarke

Novartis, Switzerland

Adrian Clarke is a Scientific Advisor in Analytics at Novartis Pharma (Basel, Switzerland). His main responsibilities are: driving scientific excellence, identifying strategic, operational and technological needs; defining, developing and implementing innovative state of the art analytics and regulatory control strategies.

He has more than 25 years’ experience working in the Pharma industry and…

[Read More]

Keynote Speakers

Alessandra Altomare

University of Milan – Italy

[Read More]
Silvio Aprile

University of Piemonte Orientale – Italy

[Read More]

Carsten Hopf

Mannheim University of Applied Sciences – Germany

[Read More]

Franz Bucar​

University of Graz – Austria

[Read More]
Sandra Furlanetto​

University of Florence – Italy

[Read More]

Davy Guillarme

University of Geneva – Switzerland

[Read More]
Sara Carillo

National Institute for Bioprocessing Research and Training (NIBRT) – Dublin, Ireland

[Read More]
Stig Pedersen-Bjergaard

University of Copenhagen – Denmark

[Read More]
Marianne Fillet

University of Liège – Belgium

[Read More]

Michael Lämmerhofer

University of
Tübingen – Germany

[Read More]

Sebastiano Pasqualato

Human Technopole

[Read More]

“Proteomics Tools in Drug Discovery”

Alessandra Altomare

University of Milan – Italy

Alessandra Altomare is an Associate Professor of Medicinal Chemistry at the University of Milan, where she earned her PhD in Pharmaceutical Sciences. An expert in mass spectrometry-based proteomics, she has published 72 scientific papers and achieved an H-index of 20. Her research focuses on the development and application of advanced high-resolution mass spectrometry (HR-MS) techniques for identifying molecular targets, studying biomarkers relevant to disease mechanisms, and elucidating the mechanisms of action of bioactive molecules… [Read More]

“Approaches and strategies in assessing drug metabolism in early and preclinical drug development: application to our medicinal chemistry projects”

Silvio Aprile

University of Piemonte Orientale – Italy

Silvio Aprile is Associate Professor of Pharmaceutical Analysis at the Department of Pharmaceutical Sciences (DSF) of the Università del Piemonte Orientale (UPO) in Novara, Italy. He is also a cofounder of the spin-off company Novanalitica Srls, operating in Novara, Italy. His current research focuses primarily on ADME-PK studies in drug discovery and lead optimization projects, particularly of novel biologically active compounds such as indoleamine 2,3-dioxygenase (IDO) inhibitors, PROTACs, and antibacterial isocyanides. His work emphasizes metabolic stability and metabolite profiling assessment, mainly through in vitro experiments and employing HPLC-UV, fluorescence (FL), and high-resolution mass spectrometry (HRMS) analytical techniques…

[Read More]

“Advances in mass spectrometry imaging for pharmaceutical R&D”

Carsten Hopf

Mannheim University of Applied Sciences – Germany

Carsten Hopf holds a PhD in Biochemistry and is a Professor of Bioanalytics, Proteomics, and Drug Discovery at Mannheim University of Applied Sciences. He is the head of CeMOS and the M²Aind partnership, serves on biomedical cluster boards, and is an Associated Professor at Heidelberg University…

[Read More]

“Analysis of flavonoids – still a challenge?”

Franz Bucar

University of Graz – Austria

Franz Bucar is Deputy Head of the Department of Pharmacognosy, Institute of Pharmaceutical Sciences, at the University of Graz, Austria, and Associate Professor in Pharmacognosy. Major research activities focus on drug discovery from traditional medicinal plants, including extraction, isolation, structure elucidation and analysis of plant constituents with antibacterial activity, and plant natural products as modulators of bacterial resistance… [Read More]

“Quality by Design and Analytical Quality by Design from regulatory requirements to pharmaceutical development“

Sandra Furlanetto

University of Florence – Italy

Sandra Furlanetto holds a PhD in Pharmaceutical Chemistry and is a Full Professor of Analytical Chemistry at the University of Florence. She serves as Editor of the Journal of Pharmaceutical and Biomedical Analysis and is a member of the Italian National University Council…

[Read More]

“Multi-Attribute Method (MAM): From Development to Deployment in Monoclonal Antibodies and Advanced Therapies Manufacturing”

Sara Carillo

National Institute for Bioprocessing Research and Training (NIBRT) – Dublin, Ireland

Dr. Sara Carillo holds a PhD in Chemical Sciences and is the Bioanalytical Research Lead at NIBRT in Dublin. Her research focuses on mass spectrometry-based analytical methods to improve the understanding of biomanufacturing processes and biopharmaceuticals’ structural complexity… [Read More]
Torna in alto